comparemela.com

Latest Breaking News On - Biologika gmb - Page 7 : comparemela.com

Takeda, IDT to manufacture doses of Johnson & Johnson COVID-19 vaccine

Article content Japan’s Takeda Pharmaceutical Co Ltd said on Monday it has signed an agreement with contract manufacturer IDT Biologika GmbH to manufacture Johnson & Johnson’s single-dose COVID-19 vaccine. J&J’s vaccine, authorized in the United States on Feb. 27, is the first single-dose coronavirus vaccine alongside two-shot vaccines from Pfizer/BioNTech and Moderna Inc . We apologize, but this video has failed to load. Try refreshing your browser, or Takeda, IDT to manufacture doses of Johnson & Johnson COVID-19 vaccine Back to video Under the contract, the capacity previously reserved to make Takeda’s dengue vaccine candidate will be used to make J&J COVID-19 vaccines instead, Takeda said.

Russia Secures Sputnik Italy Output in European Vaccine Push

Russia Secures Sputnik Italy Output in European Vaccine Push This content was published on March 9, 2021 - 18:51 March 9, 2021 - 18:51 (Bloomberg) Russia is pushing ahead with plans to manufacture its Covid-19 vaccine in Europe, securing a deal to produce the Sputnik V shot in Italy and discussing production in Germany and France. Adienne Pharma & Biotech SA signed an agreement to make the vaccine at its production site in the Milan region, founder and President Antonio Francesco Di Naro said in an interview. The Lugano, Switzerland-based company’s deal with the Russian Direct Investment Fund is the first European production agreement for the vaccine. While Russia was first to approve a shot for the general public and promoted it as a way to help end the pandemic globally, it has been slower than some rivals to scale up output.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.